Vident Advisory’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
29,196
+2,518
+9% +$95.3K 0.01% 888
2026
Q1
$954K Buy
26,678
+5,905
+28% +$215K 0.01% 896
2025
Q4
$674K Sell
20,773
-4,752
-19% -$148K 0.01% 990
2025
Q3
$720K Buy
25,525
+4,294
+20% +$123K 0.01% 995
2025
Q2
$640K Buy
21,231
+5,351
+34% +$181K 0.01% 920
2025
Q1
$649K Buy
15,880
+1,409
+10% +$67.8K 0.01% 896
2024
Q4
$784K Sell
14,471
-889
-6% -$50.9K 0.01% 744
2024
Q3
$998K Buy
15,360
+4,286
+39% +$275K 0.03% 631
2024
Q2
$686K Buy
11,074
+5,466
+97% +$380K 0.02% 736
2024
Q1
$475K Buy
5,608
+1,045
+23% +$82.9K 0.01% 838
2023
Q4
$342K Buy
+4,563
New +$317K 0.01% 939

Other funds holding CRI

Vident Advisory's CRI Position: Q2 2026 in Review

Vident Advisory increased its Carter's (CRI) stake by 9.4% in Q2 2026, buying an estimated $95.3K and bringing the position to 29,196 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #888.

Vident Advisory first reported a position in CRI in Q4 2023 and has held it in 11 quarters since. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Vident Advisory held 29,196 shares of Carter's worth $1.2M as of Q2 2026.
  • Vident Advisory bought 2,518 Carter's shares in Q2 2026, an estimated $95.3K.
  • Carter's made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #888 holding.
  • Vident Advisory first reported a position in Carter's in Q4 2023 and has held it in 11 quarters since.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.